Dow Jones

38,686.32

1.51%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Guardion Health Sciences Inc (GHSI)
Guardion Health Sciences Inc (GHSI) Noticias

GHSI

Guardion Health Sciences (GHSI)

Guardion Health Sciences Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GHSI

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
31/05/2024	15:33	GlobeNewswire Inc.	Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution	NASDAQ:GHSI	Guardion Health Sciences Inc
23/05/2024	15:56	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GHSI	Guardion Health Sciences Inc
23/05/2024	15:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GHSI	Guardion Health Sciences Inc
23/05/2024	14:00	GlobeNewswire Inc.	Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business	NASDAQ:GHSI	Guardion Health Sciences Inc
21/05/2024	07:00	GlobeNewswire Inc.	Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024	NASDAQ:GHSI	Guardion Health Sciences Inc
13/05/2024	16:01	GlobeNewswire Inc.	Guardion Health Sciences Announces	NASDAQ:GHSI	Guardion Health Sciences Inc
13/05/2024	15:46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GHSI	Guardion Health Sciences Inc
06/05/2024	15:01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GHSI	Guardion Health Sciences Inc
05/05/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:GHSI	Guardion Health Sciences Inc
29/03/2024	05:15	GlobeNewswire Inc.	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023	NASDAQ:GHSI	Guardion Health Sciences Inc
06/02/2024	09:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GHSI	Guardion Health Sciences Inc
31/01/2024	16:21	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GHSI	Guardion Health Sciences Inc
30/01/2024	17:13	GlobeNewswire Inc.	Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.	NASDAQ:GHSI	Guardion Health Sciences Inc
13/11/2023	15:10	GlobeNewswire Inc.	Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023	NASDAQ:GHSI	Guardion Health Sciences Inc
14/08/2023	07:15	GlobeNewswire Inc.	Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023	NASDAQ:GHSI	Guardion Health Sciences Inc
07/08/2023	19:47	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GHSI	Guardion Health Sciences Inc
05/07/2023	16:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GHSI	Guardion Health Sciences Inc
16/06/2023	16:02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:GHSI	Guardion Health Sciences Inc
05/06/2023	16:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GHSI	Guardion Health Sciences Inc
30/05/2023	07:00	GlobeNewswire Inc.	Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer	NASDAQ:GHSI	Guardion Health Sciences Inc
15/05/2023	07:15	GlobeNewswire Inc.	Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023	NASDAQ:GHSI	Guardion Health Sciences Inc
15/05/2023	07:01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:GHSI	Guardion Health Sciences Inc
17/04/2023	07:15	GlobeNewswire Inc.	Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022	NASDAQ:GHSI	Guardion Health Sciences Inc
17/04/2023	07:01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GHSI	Guardion Health Sciences Inc
06/03/2023	07:00	GlobeNewswire Inc.	Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value	NASDAQ:GHSI	Guardion Health Sciences Inc
08/02/2023	14:05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GHSI	Guardion Health Sciences Inc
24/01/2023	15:05	GlobeNewswire Inc.	Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements	NASDAQ:GHSI	Guardion Health Sciences Inc
11/01/2023	16:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GHSI	Guardion Health Sciences Inc
06/01/2023	15:15	GlobeNewswire Inc.	Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023	NASDAQ:GHSI	Guardion Health Sciences Inc
12/12/2022	16:16	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:GHSI	Guardion Health Sciences Inc